Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Mouth Neoplasms 3Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Recurrence 2Mycosis Fungoides 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell 2Laryngeal Neoplasms 2Vaccinia 1Sinonasal Squamous Cell Carcinoma 1Sarcoma 1Resectable Non-small Cell Lung Cancer 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Immunoblastic Lymphadenopathy 1

Interventions

Cisplatin 4Radiotherapy 3Cetuximab 3pembrolizumab 2Surveys and Questionnaires 2Carboplatin 2olaparib 1niraparib 1fludarabine 1dostarlimab 1cemiplimab 1calcipotriene 1avelumab 1atezolizumab 1aldesleukin 1Watchful Waiting 1Tiragolumab 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Platinum 1Phlebotomy 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Fluorouracil 1Fluorodeoxyglucose F18 1Docetaxel 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × cemiplimab × 30 days × Clear all
NCT05574101 2026-05-15

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
34 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡